Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Clasificación en acciones #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Precio por acción
$0.000001
Última sincronización: 2023-12-13
Capitalización bursátil
$23.51
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Allena Pharmaceuticals, Inc. (ALNAQ)

Categoría

Historial de desdoblamientos de acciones de Allena Pharmaceuticals, Inc. (ALNAQ)
La acción Allena Pharmaceuticals, Inc. (símbolo: ALNAQ) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 12, 2026.
Una acción ALNAQ comprada antes de Aug 12, 2026 equivaldría hoy a 0 acciones ALNAQ.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR